These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 15837744)
1. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer. Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744 [TBL] [Abstract][Full Text] [Related]
2. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer]. Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763 [TBL] [Abstract][Full Text] [Related]
3. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer. Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189 [TBL] [Abstract][Full Text] [Related]
4. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. David O; Jett J; LeBeau H; Dy G; Hughes J; Friedman M; Brody AR Clin Cancer Res; 2004 Oct; 10(20):6865-71. PubMed ID: 15501963 [TBL] [Abstract][Full Text] [Related]
5. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Müller-Tidow C; Metzger R; Kügler K; Diederichs S; Idos G; Thomas M; Dockhorn-Dworniczak B; Schneider PM; Koeffler HP; Berdel WE; Serve H Cancer Res; 2001 Jan; 61(2):647-53. PubMed ID: 11212263 [TBL] [Abstract][Full Text] [Related]
7. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway. Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138 [TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074 [TBL] [Abstract][Full Text] [Related]
12. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer. Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592 [TBL] [Abstract][Full Text] [Related]
14. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099 [TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]
16. Relation of epidermal growth factor receptor, phosphorylated-Akt, and hypoxia-inducible factor-1alpha in non-small cell lung cancers. Hirami Y; Aoe M; Tsukuda K; Hara F; Otani Y; Koshimune R; Hanabata T; Nagahiro I; Sano Y; Date H; Shimizu N Cancer Lett; 2004 Oct; 214(2):157-64. PubMed ID: 15363541 [TBL] [Abstract][Full Text] [Related]
17. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies. Tsao AS; McDonnell T; Lam S; Putnam JB; Bekele N; Hong WK; Kurie JM Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):660-4. PubMed ID: 12869408 [TBL] [Abstract][Full Text] [Related]
18. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785 [TBL] [Abstract][Full Text] [Related]
20. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]